Surprising merger between Sanofi-Synthelabo and Keuhwha Pharm

Published: 2002-08-08 06:59:00

Updated: 2002-08-08 06:59:00

The surprising takeover of Keuhwha Pharm by Sanofi-Synthelabo has drawn a keen interest from the domestic pharmaceutical industry, since the deal was arranged by the world's largest drug company.

Notably, as its affiliate Sanofi-Synthelabo Korea has seen its surging sales annually at a faster ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK